- Home
- MIRA
as 02-21-2025 4:00pm EST
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | MIAMI |
| Market Cap: | 18.4M | IPO Year: | 2023 |
| Target Price: | $14.00 | AVG Volume (30 days): | 223.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.57 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.51 - $5.01 | Next Earning Date: | 03-31-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest MIRA Pharmaceuticals Inc. News
MIRA Breaking Stock News: Dive into MIRA Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 months ago
Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation
CoinDesk
2 months ago
Memecoin Degens Raise Millions for Rare Cancer Research After a Father’s Plea
ACCESSWIRE
2 months ago
MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development
Benzinga
2 months ago
EXCLUSIVE: MIRA Pharmaceuticals Files FDA Application To Start Human Trials For Its Lead Pain Treatment
Zacks Small Cap Research
2 months ago
MIRA Makes Major Strides
ACCESSWIRE
2 months ago
MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End
Benzinga
2 months ago
EXCLUSIVE: MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile, Paving Way For Human Trials In Neuropathic Pain
ACCESSWIRE
3 months ago
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site
Compare MIRA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MIRA MIRA Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.